JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CURO
5201
DELISTED
CURO Group Holdings Corp.
CURO
| $93K | ﹤0.01% |
16,829
-32,865
| -66% | -$301K |
2018 Q1
17 quarters
|
|
|
SALM
5202
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $93K | ﹤0.01% |
43,811
-9,552
| -18% | -$27K |
2021 Q4
2 quarters
|
|
|
HTPA.WS
5203
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
| – | – |
0
| – | – |
2022 Q2
0 quarters
|
|
|
JBIO
5204
Jade Biosciences
JBIO
$876M
| $92K | ﹤0.01% |
168
-89
| -35% | -$42.5K |
2021 Q3
3 quarters
|
|
5205
CALL
Dell
DELL
$344B
| $92K | ﹤0.01% |
+2,000
| New | +$94.5K |
2022 Q2
0 quarters
|
|
|
TBHC
5206
DELISTED
The Brand House Collective
TBHC
| $92K | ﹤0.01% |
26,094
+20,165
| +340% | +$129K |
2020 Q2
8 quarters
|
|
5207
Purple Innovation
PRPL
$9.29M
| $92K | ﹤0.01% |
1,197
-15,309
| -93% | -$1.78M |
2018 Q3
15 quarters
|
|
5208
ProShares UltraPro Short Dow 30
SDOW
$156M
| $92K | ﹤0.01% |
619
+255
| +70% | +$33.3K |
2018 Q4
14 quarters
|
|
5209
NuScale Power
SMR
$3.2B
| $92K | ﹤0.01% |
+9,168
| New | +$91.7K |
2022 Q2
0 quarters
|
|
5210
VistaGen Therapeutics
VTGN
$12.5M
| $92K | ﹤0.01% |
3,475
+437
| +14% | +$15.4K |
2021 Q2
4 quarters
|
|
5211
Dakota Gold
DC
$802M
| $91K | ﹤0.01% |
+27,158
| New | +$108K |
2022 Q2
0 quarters
|
|
5212
Mizuho Financial
MFG
$130B
| $91K | ﹤0.01% |
41,136
+11,445
| +39% | +$27K |
2013 Q2
36 quarters
|
|
|
COUP
5213
PUT
DELISTED
Coupa Software Incorporated
COUP
| $91K | ﹤0.01% |
+1,600
| New | +$123K |
2022 Q2
0 quarters
|
|
5214
Hycroft Mining Holding Corp
HYMC
$1.76B
| $90K | ﹤0.01% |
+8,071
| New | +$120K |
2022 Q2
0 quarters
|
|
|
NOTV
5215
DELISTED
Inotiv
NOTV
| $90K | ﹤0.01% |
9,420
+1,136
| +14% | +$19K |
2015 Q4
26 quarters
|
|
5216
PUT
NovoCure
NVCR
$1.85B
| $90K | ﹤0.01% |
1,300
-75,200
| -98% | -$5.66M |
2022 Q1
1 quarter
|
|
|
SPWR
5217
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $90K | ﹤0.01% |
5,700
+5,000
| +714% | +$90.1K |
2020 Q4
6 quarters
|
|
5218
PUT
Corsair Gaming
CRSR
$1.5B
| $89K | ﹤0.01% |
+6,800
| New | +$111K |
2022 Q2
0 quarters
|
|
5219
Global X Autonomous & Electric Vehicles ETF
DRIV
$357M
| $89K | ﹤0.01% |
+4,168
| New | +$100K |
2022 Q2
0 quarters
|
|
5220
iShares MSCI Indonesia ETF
EIDO
$420M
| $89K | ﹤0.01% |
3,990
-1,227
| -24% | -$29.6K |
2022 Q1
1 quarter
|
|
5221
CALL
PagSeguro Digital
PAGS
$2.44B
| $89K | ﹤0.01% |
8,700
-149,900
| -95% | -$2.15M |
2022 Q1
1 quarter
|
|
5222
Root
ROOT
$716M
| $89K | ﹤0.01% |
4,177
-30,982
| -88% | -$839K |
2020 Q4
6 quarters
|
|
5223
Northern Trust Morningstar US Market Factor Tilt ETF
TILT
$2.18B
| $89K | ﹤0.01% |
612
| – | – |
2021 Q1
5 quarters
|
|
|
CISO
5224
CISO Global
CISO
$9.2M
| $88K | ﹤0.01% |
1,628
+1,619
| +17,989% | +$126K |
2022 Q1
1 quarter
|
|
5225
Neurogene
NGNE
$531M
| $88K | ﹤0.01% |
4,276
+2,897
| +210% | +$70.7K |
2020 Q1
9 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.